Insider Transactions in Q1 2023 at Intuitive Surgical Inc (ISRG)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,253
-39.12%
|
$285,684
$228.47 P/Share
|
|
Feb 28
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,501
-20.28%
|
$343,729
$229.39 P/Share
|
|
Feb 28
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,259
+29.6%
|
-
|
|
Feb 28
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
456
-7.83%
|
$104,424
$229.39 P/Share
|
|
Feb 28
2023
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,317
+18.17%
|
-
|
|
Feb 28
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
1,705
-8.68%
|
$390,445
$229.39 P/Share
|
|
Feb 28
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
3,679
+15.68%
|
-
|
|
Feb 28
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,617
-3.27%
|
$370,293
$229.39 P/Share
|
|
Feb 28
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
3,259
+6.13%
|
-
|
|
Feb 28
2023
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,159
-5.03%
|
$723,411
$229.39 P/Share
|
|
Feb 28
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,371
+9.17%
|
-
|
|
Feb 28
2023
|
Jamie Samath CFO and Head of Business Techn |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-5.63%
|
$159,384
$229.39 P/Share
|
|
Feb 28
2023
|
Jamie Samath CFO and Head of Business Techn |
BUY
Exercise of conversion of derivative security
|
Direct |
2,009
+13.84%
|
-
|
|
Feb 28
2023
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,865
-0.72%
|
$427,085
$229.39 P/Share
|
|
Feb 28
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+1.43%
|
-
|
|
Feb 28
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
744
-1.81%
|
$170,376
$229.39 P/Share
|
|
Feb 28
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
2,201
+5.05%
|
-
|
|
Feb 26
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-9.58%
|
$48,972
$231.05 P/Share
|
|
Feb 26
2023
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+21.57%
|
-
|
|
Feb 26
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-6.3%
|
$115,731
$231.05 P/Share
|
|
Feb 26
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+16.66%
|
-
|
|
Feb 26
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-29.06%
|
$136,752
$231.05 P/Share
|
|
Feb 26
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+45.64%
|
-
|
|
Feb 26
2023
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-5.04%
|
$334,719
$231.05 P/Share
|
|
Feb 26
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,030
+9.53%
|
-
|
|
Feb 26
2023
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
848
-0.66%
|
$195,888
$231.05 P/Share
|
|
Feb 26
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+1.32%
|
-
|
|
Feb 26
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-1.99%
|
$89,397
$231.05 P/Share
|
|
Feb 26
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+6.19%
|
-
|
|
Feb 26
2023
|
Jamie Samath CFO and Head of Business Techn |
SELL
Payment of exercise price or tax liability
|
Direct |
445
-8.46%
|
$102,795
$231.05 P/Share
|
|
Feb 26
2023
|
Jamie Samath CFO and Head of Business Techn |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+19.62%
|
-
|
|
Feb 26
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
848
-3.63%
|
$195,888
$231.05 P/Share
|
|
Feb 26
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+6.83%
|
-
|
|
Feb 16
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
116
-6.74%
|
$27,840
$240.77 P/Share
|
|
Feb 16
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,124
-77.46%
|
$269,760
$240.77 P/Share
|
|
Feb 16
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,971
-23.64%
|
$473,040
$240.77 P/Share
|
|
Feb 15
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
868
-3.86%
|
$211,792
$244.77 P/Share
|
|
Feb 15
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
1,749
+7.21%
|
-
|
|
Feb 15
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-8.55%
|
$39,284
$244.77 P/Share
|
|
Feb 15
2023
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
393
+17.27%
|
-
|
|
Feb 15
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
625
-30.11%
|
$152,500
$244.77 P/Share
|
|
Feb 15
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,749
+45.73%
|
-
|
|
Feb 15
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
666
-7.4%
|
$162,504
$244.77 P/Share
|
|
Feb 15
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
2,124
+19.09%
|
-
|
|
Feb 15
2023
|
Jamie Samath CFO and Head of Business Techn |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-6.43%
|
$66,612
$244.77 P/Share
|
|
Feb 15
2023
|
Jamie Samath CFO and Head of Business Techn |
BUY
Exercise of conversion of derivative security
|
Direct |
723
+14.54%
|
-
|
|
Feb 15
2023
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,308
-4.84%
|
$319,152
$244.77 P/Share
|
|
Feb 15
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+12.18%
|
-
|
|
Feb 15
2023
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,116
-0.87%
|
$272,304
$244.77 P/Share
|
|
Feb 15
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+1.73%
|
-
|